Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide for Cocaine Use Disorder
NCT07227948Phase 2Recruiting
- Sponsor
- UTHealth Houston
- Start
- Jan 2026
- Primary completion
- Jan 2029
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of semaglutide in cocaine use disorder (CUD), sponsored by UTHealth Houston. Started Jan 2026; status: recruiting.
02
Drugs
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT07227948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07227948.